Mélanie Bérubé

Mélanie Bérubé has been in the biopharmaceutical industry since 2005. Mélanie began their career at Medicago, where they held the roles of Director-Preclinical Studies, Manager Preclinical Studies, Project Leader, and Postdoctoral Fellow. In 2020, they moved to ANGANY as Senior Director, Clinical Development. Currently, they are working at Providence Therapeutics as Senior Director Preclinical/Nonclinical Studies.

Mélanie Bérubé obtained their Doctorate in Molecular Endocrinology from Université Laval between 2001 and 2005, specializing in Oncology and Cancer Biology.